Novavax, Inc. (NVAX): Price and Financial Metrics

Novavax, Inc. (NVAX)

Today's Latest Price: $111.63 USD

1.48 (1.34%)

Updated Sep 22 4:00pm

Add NVAX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 373 in Biotech

See all "A" rated Strong Buy stocks

NVAX Stock Summary

  • The price/operating cash flow metric for Novavax Inc is higher than 98.16% of stocks in our set with a positive cash flow.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -7.42 for Novavax Inc; that's greater than it is for merely 2.3% of US stocks.
  • In terms of volatility of its share price, NVAX is more volatile than 99.06% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Novavax Inc, a group of peers worth examining would be AGIO, SYRS, CNCE, BBIO, and RGNX.
  • NVAX's SEC filings can be seen here. And to visit Novavax Inc's official web site, go to
NVAX Daily Price Range
NVAX 52-Week Price Range

NVAX Stock Price Chart Technical Analysis Charts

NVAX Price/Volume Stats

Current price $111.63 52-week high $189.40
Prev. close $110.15 52-week low $3.54
Day low $106.15 Volume 2,403,607
Day high $112.40 Avg. volume 8,491,896
50-day MA $128.26 Dividend yield N/A
200-day MA $50.77 Market Cap 6.84B

Novavax, Inc. (NVAX) Company Bio

Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.

NVAX Latest News Stream

Event/Time News Detail
Loading, please wait...

NVAX Latest Social Stream

Loading social stream, please wait...

View Full NVAX Social Stream

Latest NVAX News From Around the Web

Below are the latest news stories about Novavax Inc that investors may wish to consider to help them evaluate NVAX as an investment opportunity.

Novavax, Inc. (NVAX) Management Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)

Novavax, Inc. (NVAX) Morgan Stanley 18th Annual Global Healthcare Conference September 16, 2020 12:30 PM ET Company Participants John Trizzino - Chief Business Officer and CFO Greg Glenn - President, Research and Development Conference Call Participants Matthew Harrison - Morgan Stanley Presentation Matthew Harrison Great. Well thanks for joining us...

SA Transcripts on Seeking Alpha | September 16, 2020

Novavax Expands Coronavirus Vaccine Manufacturing Deal in India

Novavax (NVAX) amends its present contract with Serum Institute of India Private Limited to widen the manufacturing capacity of its COVID-19 vaccine candidate NVX-CoV2373 to 2 billion plus doses in 2021.

Yahoo | September 16, 2020

Novavax, Inc. (NVAX) Management Presents at Cantor Virtual Global Healthcare Conference (Transcript)

Novavax, Inc. (NVAX) Cantor Virtual Global Healthcare Conference Transcript September 15, 2020 11:20 AM ET Executives Stan Erck - Chief Executive Officer Dr. Greg Glenn - Chief Scientific Officer Analysts Charles Duncan - Cantor Presentation Charles Duncan [Started Abruptly] … Global Healthcare Conference. And it’s a pleasure to introduce the...

SA Transcripts on Seeking Alpha | September 15, 2020

Novavax doubles aims for 2 billion Covid-19 vaccine doses with expanded India deal

In August, the US drugmaker had signed a deal with the Serum Institute of India, the world’s largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate.

Hindustan Times | September 15, 2020

Novavax aims for 2 billion Covid-19 vaccine doses with expanded India deal | India News - Times of India

India News: US drug developer Novavax Inc said on Tuesday it was doubling its potential Covid-19 vaccine manufacturing capacity to two billion doses annually unde.

The India Times | September 15, 2020

Read More 'NVAX' Stories Here

NVAX Price Returns

1-mo -18.89%
3-mo 44.04%
6-mo 776.22%
1-year 1,660.73%
3-year 381.16%
5-year -39.27%
YTD 2,704.77%
2019 -89.18%
2018 48.39%
2017 -1.59%
2016 -84.98%
2015 41.48%

Continue Researching NVAX

Want to see what other sources are saying about Novavax Inc's financials and stock price? Try the links below:

Novavax Inc (NVAX) Stock Price | Nasdaq
Novavax Inc (NVAX) Stock Quote, History and News - Yahoo Finance
Novavax Inc (NVAX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6827 seconds.